Industry-INTERPOL anti-counterfeiting agreement highlights benefits of pooled resources

An agreement between INTERPOL and 29 pharmaceutical companies, announced yesterday, will lead to the establishment of a new €4.5 million programme to combat fake medicines. The deal also demonstrates the advantages of pooling resources to work collaboratively with authorities against shared threats.

Unlock unlimited access to all WTR content